drug

MRI scan

MRI Scan

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

DEVICE

Pre-approval / investigational in the US

Developed by Jeffrey A. Lieberman, MD

3 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

DEVICE

Indications

Investigational (via trials)

Schizophrenia Substance-Related Disorders Depression Schizophrenia Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)Psychotic Disorders Personality Disorders

Trials

Energetics and Glutamate in Schizophrenia

NCT06236048—Recruiting

Brain Imaging in Early Psychosis

NCT03932188—Unknown

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

NCT02983058—Terminated

KOLs & investigators

Sander Markx, MD

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Jeffrey A. Lieberman, MD

company

trial

Energetics and Glutamate in Schizophrenia

trial

Brain Imaging in Early Psychosis

trial

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

trial

indication

Schizophrenia

indication

Substance-Related Disorders

indication

Depression

indication

Schizophrenia

indication

KOL

Sander Markx, MD

KOL score —

person